StonvexLoading…
StonvexStonvexStonvexCore line items from PGY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.26B | $1.00B | $772.81M | $685.41M |
Operating Income | $263.83M | $66.84M | $-24.40M | $-251.50M |
Net Income | $81.39M | $-401.41M | $-128.44M | $-302.32M |
EPS (Diluted) | $0.93 | $-5.66 | $-2.14 | $-8.22 |
Total Assets | $1.55B | $1.29B | $1.21B | $1.05B |
Total Liabilities | $960.46M | $775.28M | $468.38M | $279.66M |
Cash & Equivalents | $235.33M | $187.92M | $186.48M | $309.79M |
Free Cash Flow OCF − CapEx | $224.72M | $30.01M | $-41.85M | $-62.41M |
Shares Outstanding | 83.10M | 70.88M | 60.04M | 38.25M |